Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Pancrease

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Background: Pancreatic enzyme replacement therapy (PERT) improves nutritional status and growth in patients with cystic fibrosis… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Primary Sjögren's syndrome (pSS) is one of the autoimmune diseases with high incidence. There were several clinical… Expand
Is this relevant?
2005
2005
Pancreatic function tests were performed in 11 adult cystic fibrosis (CF) patients with a fecal fat excretion of more than 10… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
1997
1997
Choosing the optimum pancreatic enzyme replacement therapy for patients with exocrine insufficiency remains a problem. An enteric… Expand
Is this relevant?
1996
1996
Objectives: Enteric‐coated microsphere/microtablet pancreatin should stay intact in the stomach and dissolve promptly on entering… Expand
Is this relevant?
Highly Cited
1991
Highly Cited
1991
We studied the effect of the addition of omeprazole (20 mg once a day) to treatment with pancreatin (Pancrease, Cilag, Herentals… Expand
Is this relevant?
1990
1990
Pancreatic enzyme products are formulated, manufactured, and sold without submitting efficacy or bioavailability data to the Food… Expand
Is this relevant?
1988
1988
In order to avoid inactivation in the stomach, pancreatic enzymes have been prepared as pH-sensitive, enteric-coated microspheres… Expand
Is this relevant?
Highly Cited
1987
Highly Cited
1987
Four different pancreatin products, Pancrease, Creon, Pancrex V Forte, and Pancreatin Merck, were compared in a random crossover… Expand
Is this relevant?
1982
1982
ABSTRACT. Pancreatic extracts, even in high doses, usually fail to completely control steatorrhoea in cystic fibrosis (CF), due… Expand
Is this relevant?